Markus Gemuend

Markus Gemuend is a biopharmaceutical executive with more than two decades of experience advancing vaccines and biologics from early development through global commercialization. He joins Adjuvant Capital as a Senior Advisor, bringing deep expertise in product development, manufacturing scale-up, and cross-sector partnerships that expand access to essential health technologies. Markus has held leadership roles spanning R&D, operations, and market introduction within both multinational pharmaceutical companies and global health organizations. At Adjuvant, he will advise on industrialization strategies, technology transfer, and partnerships that accelerate the delivery of affordable, high-quality health products worldwide.